Clinical trial
FutureMS-2: Clinical, Laboratory, and Genomic Predictors of Disease Activity in People Diagnosed With Relapsing Onset Multiple Sclerosis: an Observational Cohort and Scottish Precision Medicine Study
NCT06001138 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FutureMS-2: Clinical, Laboratory, and Genomic Predictors of Disease Activity in People Diagnosed With Relapsing Onset Multiple Sclerosis: an Observational Cohort and Scottish Precision Medicine Study
- Lead sponsor
- University of Edinburgh
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- October 7, 2021
- Completion date
- September 30, 2029
- Enrollment
- 440 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.